GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Applied Biosciences Corp (OTCPK:APPB) » Definitions » Net Change in Cash

APPB (Applied Biosciences) Net Change in Cash : $-0.22 Mil (TTM As of Dec. 2019)


View and export this data going back to 2015. Start your Free Trial

What is Applied Biosciences Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Applied Biosciences's Net Change in Cash for the three months ended in Dec. 2019 was $-0.05 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2019 was $-0.22 Mil.

Applied Biosciences Net Change in Cash Historical Data

The historical data trend for Applied Biosciences's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied Biosciences Net Change in Cash Chart

Applied Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
Net Change in Cash
0.01 -0.01 - 0.21 -0.15

Applied Biosciences Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 -0.19 -0.01 0.04 -0.05

Applied Biosciences Net Change in Cash Calculation

Applied Biosciences's Net Change in Cash for the fiscal year that ended in Mar. 2018 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.673+-0.173+0.695+0
=-0.15

Applied Biosciences's Net Change in Cash for the quarter that ended in Dec. 2019

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.052+0+0+0
=-0.05

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Applied Biosciences's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Applied Biosciences Corp (OTCPK:APPB) » Definitions » Net Change in Cash
Comparable Companies
CNABQ OWCP CXUS CANB GSRX LITH GENH PCYN EVIO ACCA ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601
Traded in Other Exchanges
N/A
Address
112 North Curry Street, 18th Floor, Carson, NY, USA, 89703
Website
https://www.appliedbiocorp.com
Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.
Executives
Michael Beaubaire director 9701 WILSHIRE BLVD. SUITE 1000 BEVERLY HILLS CA 90212
John Robert Brady 10 percent owner 9701 WILSHIRE BLVD., SUITE 1000 BEVERLY HILLS CA 90212
Raymond W. Urbanski director, officer: Chief Executive Officer 28903 NORTH AVENUE PAINE, VALENCIA CA 91355
Scott B Stevens director 9701 WILSHIRE BLVD., SUITE 1000, BEVERLY HILLS CA 90212
Chris Bridges director, officer: President 9701 WILSHIRE BLVD., SUITE 1000 BEVERLY HILLS CA 90212
John James Southard officer: Secretary and Treasurer 9701 WILSHIRE BLVD., SUITE 1000 BEVERLY HILLS CA 90212
Sbs Family Trust 10 percent owner 521 RXR PLAZA EAST TOWER ? SUITE 521 UNIONDALE NY 11556